IBM and GeneFormatics Partner to Accelerate Drug Discovery
Agreement puts information technology to work in determining protein function and structure
24-Dec-2001 -
ARMONK, N.Y. and SAN DIEGO, Calif., December 18, 2001 . . . IBM and GeneFormatics, Inc. today announced an agreement that could pave the way for more efficient drug discovery.
Through the agreement, IBM becomes GeneFormatics' preferred information technology and services partner. IBM will ...
amino acids
diseases
IBM
+6